TMDX · Company research
TransMedics Group, Inc. Common Stock (TMDX): Valuation Analysis
Available valuation snapshots and ratios; unavailable metrics remain blank.
RESEARCH CONTEXT
Understand the numbers
Available valuation snapshots and ratios; unavailable metrics remain blank. Use period, currency, units and source fields when interpreting values.
1records availableHealthcare
Valuation Analysis data
Database-backed records only
| valuation date | price | market cap | enterprise value | pe | forward pe | peg | price sales | price book | price fcf |
|---|---|---|---|---|---|---|---|---|---|
| Oct 8, 2026 | 80.28 | $3,422,424,713.89 | 2949749713.89 | 205.0487804878048780 | — | — | 18.0176928100848653 | 6.6063215807842055 | 334.97354545267691102784 |
Informational research only, not financial advice. Forecasts are uncertain and can be wrong.